Insights › Market reaction

Why Tonix Pharmaceuticals Holding (TNXP) Stock Fell 12.30% in 10 Minutes After Q3 Earnings on Nov 9, 2026

EPS of -$2.89 came in below the -$2.31 estimate; revenue of $17.2 million came in above the $16.72 million estimate.

Published in ET: Feed time in ET: Earnings TNXP -12.30% in 10 min after the headline
  • TNXP fell 12.30% in the 10 minutes after the 07:03:48 ET headline, from $4.47 to $3.92.
  • 12,775 shares changed hands in those 10 minutes.
  • The headline crossed in pre-market trading, 2 hours 27 minutes before the 9:30 ET open.
TNXP Why Tonix Pharmaceuticals Holding (TNXP) Stock Fell 12.30% in 10 Minutes After Q3 Earnings on Nov
MoveSurge publish 07:03:48 ET
MoveSurge publish
07:03:48 ET
4.52 4.28 4.03 3.79 4.10 07:01 07:03 07:20
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
TNXP 4.47 4.47 4.36 3.92 -2.46% -12.30%

Tonix Pharmaceuticals Holding (TNXP) shares fell 12.30% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 07:03:48 ET on Monday, November 9, 2026. EPS of -$2.89 came in below the -$2.31 estimate; revenue of $17.2 million came in above the $16.72 million estimate.

TNXP in the first 10 minutes

The line that crossed at 07:03:48 ET: “TNXP Q3: EPS -2.89 vs -2.31 est; revenue USD 17.2mln vs USD 16.72mln est”

From a reference price of $4.47 just before the headline, the stock was down 2.46% after one minute and down 12.30%, at $3.92, after 10 minutes. The move kept building after the first minute. 12,775 shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 2 hours 27 minutes before the 9:30 ET open.

Tonix Pharmaceuticals Holding Q3 results against estimates

MeasureReportedEstimateResult
EPS-$2.89-$2.31Miss
Revenue$17.2 million$16.72 millionBeat

How TNXP traded after earlier earnings releases

ReportEPS vs estimateRevenue vs estimateFirst move
Aug 10, 2026-2.44 vs -2.64—-6.38% in 15 min

Tonix Pharmaceuticals Holding at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$79 million (as of Nov 9, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

How did Tonix Pharmaceuticals Holding stock react to its Q3 earnings on November 9, 2026?

The stock fell 12.30% in the 10 minutes after its Q3 results crossed at 07:03:48 ET. EPS of -$2.89 came in below the -$2.31 estimate; revenue of $17.2 million came in above the $16.72 million estimate.

How far did TNXP move after the headline?

From $4.47 just before the headline to $3.92 10 minutes later, a -12.30% move.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Go live — 7 days for $29 Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.